close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Market Outlook Europe Markets Jobs
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Amazon/com Inc Tencent Holdings Ltd Hims & Hers Health Inc
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Obesity Eli Lilly and Co Labor unions
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Eli Lilly and Co Labor unions Transportation Infrastructure
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Social issues Companies Health care industry
From CNBC.com News
5 things to know before the stock market opens Wednesday
Tags Politics Investment strategy Business
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Astellas Pharma Inc Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags DR Horton Inc Autozone Inc Eli Lilly and Co
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Tickers NEWS NVO
Tags wegovy Market News News
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
Tags Breaking News: Politics Business News Eli Lilly and Co
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Eli Lilly and Co Health care industry Pharmaceuticals
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Health care industry Social issues Healthy Returns
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
Tags Higher education Business Technology
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Novo Nordisk A/S World Markets Interest Rates
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Business News Eli Lilly and Co Business
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Novo Nordisk A/S Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Health care industry Social issues Healthy Returns
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Economy Business Politics
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Eli Lilly and Co Breaking News: Markets Business News
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Health care industry Companies Business
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags Breaking News: Technology Technology Costco Wholesale Corp
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Pharmaceuticals Companies Health care industry
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Merck & Co Inc
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Health care industry Companies Social issues
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Healthy Returns Eli Lilly and Co Health care industry
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Business Breaking news Breaking News: Business
From CNBC.com News
Eli Lilly's weight loss drug Zepbound cuts heart failure risks in late-stage study
Tags US: News Biotechnology Health & Science
From CNBC.com News
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Health care industry Eli Lilly and Co Healthy Returns
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today